| 沙美特罗/丙酸氟替卡松联合治疗慢性阻塞性肺疾病研究进展 |
| |
| 引用本文： | 王瑾. 沙美特罗/丙酸氟替卡松联合治疗慢性阻塞性肺疾病研究进展[J]. 医学综述, 2011, 17(8): 1212-1214 |
| |
| 作者姓名： | 王瑾 |
| |
| 作者单位： | 上海市市北医院呼吸科,上海,200435 |
| |
| 摘 要： | 慢性阻塞性肺疾病(COPD)是呼吸系统的常见病和多发病。现通过对丙酸氟替卡松/沙美特罗(ICS/LABA)在COPD治疗中的作用机制及研究进展进行综述,阐述沙美特罗/丙酸氟替卡松联合治疗可显著降低COPD患者呼吸道炎症、显著改善1秒最大呼气量(FEV1)、FEV1减退率、急性加重次数及生活质量,降低COPD患者所有原因病死率,而且耐受性良好,是COPD患者有效、安全的治疗方法。
|
| 关 键 词： | 沙美特罗/丙酸氟替卡松 慢性阻塞性肺疾病 联合治疗 |
Progress on Treatment of Chronic Obstructive Pulmonary Disease Using Salmeterol/Fluticasone Combination Therapy |
| |
| WANG Jin. Progress on Treatment of Chronic Obstructive Pulmonary Disease Using Salmeterol/Fluticasone Combination Therapy[J]. Medical Recapitulate, 2011, 17(8): 1212-1214 |
| |
| Authors: | WANG Jin |
| |
| Affiliation: | WANG Jin1,LIN Wan-long2.(1.Department of Respiratory,2.Department of Internal Medicine,Shibei Hospital,Shanghai 200435,China) |
| |
| Abstract: | Chron ic obstructive pu lmonary d isease is a common and frequently occurred resp iratory d is-ease,th is article reviews the m echan ism and the progress of treating COPD w ith ICS /LABA(Salm eterol/Flu-ticasone),and it states that comb ination therapy w ith Salm eterol/Fluticasone sign ificantly reduce airway in-flammatory of COPD,improve FEV1 and FEV1 decline rate,reduce the frequency of exacerbations,improve the quality of life,reduce all cause mortality of COPD patients,and it has good tolerance.Theref... |
| |
| Keywords: | Salmeterol/Fluticasone Chronic obstructive pulmonary disease Combination therapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
